Anonymous
Guest
Anonymous
Guest
I was a Gilenya patient from January until June when I stopped the medication.
I'm not certain I will ever be back to whatever normal is with MS. I developed Meningeal enhancement of the brain of the Dura while on Gilenya ( [pachymeningitis). Six months later after stopping Gilenya, I am not better and the dural inflammation has now moved to the cervical spine in addition to the brain.
These side effects were not listed in the clinical trials. Although I reported my experience to the FDA and Novartis, there has not been a response from either entity requesting any information about the adverse reaction I've experienced.
I understand that the more people take a new medicine, the more side effects will be experienced, some negative. I was hoping this would be a good drug.
I'm not certain I will ever be back to whatever normal is with MS. I developed Meningeal enhancement of the brain of the Dura while on Gilenya ( [pachymeningitis). Six months later after stopping Gilenya, I am not better and the dural inflammation has now moved to the cervical spine in addition to the brain.
These side effects were not listed in the clinical trials. Although I reported my experience to the FDA and Novartis, there has not been a response from either entity requesting any information about the adverse reaction I've experienced.
I understand that the more people take a new medicine, the more side effects will be experienced, some negative. I was hoping this would be a good drug.